The Master Regulator Protein BAZ2B Can Reprogram Human Hematopoietic Lineage-Committed Progenitors into a Multipotent State

K. Arumugam(Centre for Genomic Regulation), William Shin(Columbia University), Valentina Schiavone(Centre for Genomic Regulation), Lukas Vlahos(Columbia University), Xiaochuan Tu(Universitat Pompeu Fabra), Davide Carnevali(Centre for Genomic Regulation), Jordan S. Kesner(Columbia University), Evan Paull(Columbia University), Neus Romo(Centre for Genomic Regulation), Prem S. Subramaniam(Columbia University), Jeremy Worley(Columbia University), Xiangtian Tan(Columbia University), Andrea Califano(Columbia University Irving Medical Center), Maria Pia Cosma(Institució Catalana de Recerca i Estudis Avançats)
Cell Reports
December 1, 2020
Cited by 34Open Access
Full Text

Abstract

murine embryonic stem cells with EBV-transformed human B cell lymphocytes, leads to the generation of bi-species heterokaryons. Human mRNA transcript profiling at multiple time points permits the tracking of the reprogramming of B cell nuclei to a multipotent state. Interrogation of a human B cell regulatory network with gene expression signatures identifies 8 candidate master regulator proteins. Of these 8 candidates, ectopic expression of BAZ2B, from the bromodomain family, efficiently reprograms hematopoietic committed progenitors into a multipotent state and significantly enhances their long-term clonogenicity, stemness, and engraftment in immunocompromised mice. Unbiased systems biology approaches let us identify the early driving events of human B cell reprogramming.


Related Papers

No related papers found

Powered by citation graph analysis